The Food and Drug Administration (FDA) has released first-of-its-kind draft guidance on the “unique” considerations that researchers should take into account when studying psychedelics, which the agency says show “initial promise” as potential therapies. Two days after bipartisan congressional lawmakers filed a bill to direct the issuance of such guidance, FDA published a 14-page draft … Continue reading FDA Releases First-Ever Draft Guidance For Psychedelics Research, Days After Congressional Lawmakers File Bill Asking For It